Yeast as a model for medical and medicinal research

被引:148
作者
Mager, WH
Winderickx, J
机构
[1] Free Univ Amsterdam, Fac Sci, Dept Chem & Pharmaceut Sci, NL-1081 HV Amsterdam, Netherlands
[2] Katholieke Univ Leuven, Dept Biol, B-3001 Heverlee, Belgium
关键词
D O I
10.1016/j.tips.2005.03.004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In the past, studies using the yeast Saccharomyces cerevisiae enabled major breakthroughs in the understanding of basic cellular and molecular processes. Today, the use of yeast is undergoing a 'rebirth' in both fundamental and applied research. Indeed, advances in yeast technology have paved the way for a variety of new genome-wide screening approaches. Experimental strategies using yeast aim to unravel disease-related molecular events and to discover novel medicinal compounds. In this article, the impact of yeast as an experimental tool for disease-related studies is summarized and the use of yeast in high-throughput screenings for pharmacological purposes is evaluated. The recently applied and promising approach of so-called humanized yeast systems is also discussed.
引用
收藏
页码:265 / 273
页数:9
相关论文
共 62 条
  • [1] A genome-wide screen in Saccharomyces cerevisiae reveals altered transport as a mechanism of resistance to the anticancer drug bleomycin
    Aouida, M
    Pagé, N
    Leduc, A
    Peter, M
    Ramotar, D
    [J]. CANCER RESEARCH, 2004, 64 (03) : 1102 - 1109
  • [2] Aronheim A, 2001, METHOD ENZYMOL, V332, P260
  • [3] Isolation of drugs active against mammalian prions using a yeast-based screening assay
    Bach, S
    Talarek, N
    Andrieu, T
    Vierfond, JM
    Mettey, Y
    Galons, H
    Dormont, D
    Meijer, L
    Cullin, C
    Blondel, M
    [J]. NATURE BIOTECHNOLOGY, 2003, 21 (09) : 1075 - 1081
  • [4] Yeast genome-wide drug-induced haploinsufficiency screen to determine drug mode of action
    Baetz, K
    McHardy, L
    Gable, K
    Tarling, T
    Rebérioux, D
    Bryan, J
    Andersen, RJ
    Dunn, T
    Hieter, P
    Roberge, M
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (13) : 4525 - 4530
  • [5] A three-hybrid approach to scanning the proteome for targets of small molecule kinase inhibitors
    Becker, F
    Murthi, K
    Smith, C
    Come, J
    Costa-Roldán, N
    Kaufmann, C
    Hanke, U
    Degenhart, C
    Baumann, S
    Wallner, W
    Huber, A
    Dedier, S
    Dill, S
    Kinsman, D
    Hediger, M
    Bockovich, N
    Meier-Ewert, S
    Kluge, AF
    Kley', N
    [J]. CHEMISTRY & BIOLOGY, 2004, 11 (02): : 211 - 223
  • [6] A genome-wide screen in Saccharomyces cerevisiae for genes affecting UV radiation sensitivity
    Birrell, GW
    Giaever, G
    Chu, AM
    Davis, RW
    Brown, JM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (22) : 12608 - 12613
  • [7] Development of a rapid yeast estrogen bioassay, based on the expression of green fluorescent protein
    Bovee, TFH
    Helsdingen, RJR
    Koks, PD
    Kuiper, HA
    Hoogenboom, RLAP
    Keijer, J
    [J]. GENE, 2004, 325 : 187 - 200
  • [8] HMGB1 inhibits cell death in yeast and mammalian cells and is abundantly expressed in human breast carcinoma
    Brezniceanu, ML
    Völp, K
    Bösse, S
    Solbach, C
    Lichter, P
    Joos, S
    Zörnig, M
    [J]. FASEB JOURNAL, 2003, 17 (08) : 1295 - +
  • [9] A chemical genomics approach toward understanding the global functions of the target of rapamycin protein (TOR)
    Chan, TF
    Carvalho, J
    Riles, L
    Zheng, XFS
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (24) : 13227 - 13232
  • [10] Cismowski MJ, 2002, METHOD ENZYMOL, V344, P153